All In Biotech

Drug Trial Radar · NCT02968368

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

A Phase 3, Randomized, Placebo Controlled, Prospective, Multicenter Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

Last checked: Nov 20, 2026Latest source record: Nov 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 167 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

167

Actual

Start

Dec 1, 2016

Primary completion

Jan 18, 2018

Study completion Oct 10, 2018

Sponsor

Lead sponsor
Shield TherapeuticsIndustry
Sponsor type
Industry
First posted
Nov 18, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy of oral ferric maltol compared with placebo in the treatment of IDA in subjects with CKD

Conditions

  • Renal Insufficiency, Chronic
  • Iron-Deficiency Anemia

Interventions

  • Ferric maltolDrug

  • PlaceboOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Hb Concentration From Baseline to Week 16Time frame: 16 weeks

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Peoria, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Prescott, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    La Mesa, California

  • Site not named

    Long Beach, California

  • Site not named

    Roseville, California

  • Site not named

    Sacramento, California

  • Site not named

    Denver, Colorado

  • Site not named

    Coral Springs, Florida

  • Site not named

    Edgewater, Florida

  • Site not named

    Lauderdale Lakes, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Macon, Georgia

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Pontiac, Michigan

  • Site not named

    Roseville, Michigan

  • Site not named

    Las Vegas, Nevada

  • Site not named

    Asheville, North Carolina

  • Site not named

    Charlotte, North Carolina

  • Site not named

    Wilmington, North Carolina

  • Site not named

    Bethlehem, Pennsylvania

  • Site not named

    Knoxville, Tennessee

  • Site not named

    Nashville, Tennessee

  • Site not named

    El Paso, Texas

  • Site not named

    San Antonio, Texas

  • Site not named

    Hampton, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.